None listed
Conditions
Interventions
Intervention1: Product1 Oil
Product2 Oil
Product3 Oil
Product4 Cream
Product5 Lotion
Product6 Solution: The 40 micro liter of each products will be loaded in IQ chambers and same will be pasted on th
Sponsors
Dabur India Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1Subjects in age group 18 - 55 years. 2Healthy male & female subjects. 3.Subjects with Fitzpatrick skin type III to V. 4.Subjects willing to give a written informed consent. 5.Subjects willing to maintain the patch test in position for 24 hours. 6.Subject having not participated in a similar investigation in the past two weeks. 7.Subjects willing to come for regular follow up visits. 8.Subjects ready to follow instructions during the study period. 9.Subjects with sensitive skin type as per the score obtained on the skin type identification questionnaire in annexure-I and by dermatological evaluation for the confirmation of the same.
Exclusion criteria
Exclusion criteria: •Infection, allergy on the tested area. •Skin allergy antecedents or atopic subjects. •Athletes and subjects with history of excessive sweating. •Cutaneous disease which may influence the study result. •Subjects on oral corticosteroid >10mg/day. •Subjects participating in any other cosmetic or therapeutic study. •Any history of underlying uncontrolled medical illness including diabetes, liver disease or history of alcoholism, HIV or any other serious medical illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The objective of this study is to evaluate the dermatological safety of the investigational products on healthy human subjectsTimepoint: 0hr,24hr and 7days post patch removal | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Sapna R
MS Clinical Research Pvt Ltd
Outcome results
None listed